ELAB (PMGC Holdings) 12-1 Month Momentum %: -99.34% (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ELAB PMGC Holdings Inc ELAB
8 GF Score
Price $6.66
! 3 Warning Signs
View Full Analysis

What is PMGC Holdings 12-1 Month Momentum %?

PMGC Holdings ELAB +9.18% 8 12-1 Month Momentum % is -99.34% as of Aug. 23, 2026. GuruFocus rates ELAB with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 1,359 Biotechnology companies, PMGC Holdings ranks worse than 99.48% on this metric.

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-23), PMGC Holdings's 12-1 Month Momentum % is -99.34%.

The industry rank for PMGC Holdings's 12-1 Month Momentum % or its related term are showing as below:

ELAB's 12-1 Month Momentum % is ranked worse than
99.48% of 1359 companies
in the Biotechnology industry
Industry Median: -20 vs ELAB: -99.34

PMGC Holdings  (NAS:ELAB) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


PMGC Holdings 12-1 Month Momentum % Related Terms


ELAB vs REVB, ENSC, GNPX: 12-1 Month Momentum % Comparison

For the Biotechnology subindustry, PMGC Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PMGC Holdings 12-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PMGC Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where PMGC Holdings's 12-1 Month Momentum % falls into.


ELAB
8GF Score
PMGC Holdings Inc ELAB
12-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PMGC Holdings  (NAS:ELAB) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 12-1 Month Momentum % →
What does a 12-1 Month Momentum % of -99.34% mean?
PMGC Holdings (ELAB) has a 12-1 Month Momentum % of -99.34% as of Aug. 23, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on PMGC Holdings and its competitors. According to the industry distribution chart, PMGC Holdings ranks #1352 out of 1359 companies in the Biotechnology industry, placing it in the top 99.5%.
Is PMGC Holdings' 12-1 Month Momentum % too high?
PMGC Holdings' current 12-1 Month Momentum % is -99.34%. Based on the distribution chart, PMGC Holdings ranks #1352 out of 1359 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PMGC Holdings has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PMGC Holdings' 12-1 Month Momentum % compare to REVB and ENSC?
According to the Biotechnology industry distribution chart, PMGC Holdings ranks #1352 out of 1359 companies for 12-1 Month Momentum %. This places PMGC Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Biotechnology company?
A good 12-1 Month Momentum % depends on the Biotechnology industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on PMGC Holdings and its competitors. PMGC Holdings's current 12-1 Month Momentum % is -99.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMGC Holdings stock overvalued right now?
PMGC Holdings (ELAB) has a current 12-1 Month Momentum % of -99.34%. The current 12-1 Month Momentum % is -99.34%. PMGC Holdings' overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For PMGC Holdings (ELAB), the current 12-1 Month Momentum % is -99.34% as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMGC Holdings Business Description

Address C/O 120 Newport Center Drive, Suite 250, Newport Beach, CA, USA, 92660
PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
8GF Score

Get the complete analysis for ELAB

12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.66
Price